Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies 2026-05-29 22:10
Doctors at Omotesando Helene Clinic Publish New Study on Long-Term Safety Surveillance Following High-Dose Intravenous MSC Administration 2026-05-29 13:50
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting 2026-05-29 00:02
Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion 2026-05-28 21:25
PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure 2026-05-28 19:00
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery 2026-05-28 11:10
Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease 2026-05-28 10:43
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery 2026-05-28 10:37
Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer 2026-05-28 08:00
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test 2026-05-28 06:00
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery 2026-05-27 20:00
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV 2026-05-27 19:00
Announcement of The Shaw Laureates 2026 2026-05-27 17:36
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine 2026-05-26 14:38
sweelin® Approved in Singapore as a Food Additive expanding Amai Proteins' Regulatory Footprint into Asia 2026-05-25 16:00
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan 2026-05-22 14:45
Nuance Pharma Announces IND Clearance for Actair® Pivotal Clinical Trial in China 2026-05-22 09:50
Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS 2026-05-21 22:08
Singapore Court of Appeal Notes No Finding of Fraud Against KBP or Dr. Huang; Dispute with Novo Nordisk Undergoing Arbitration Proceedings 2026-05-21 08:52
Pictor and Disease Research Limited Formalise Collaboration to Advance Johne's Disease Monitoring Across New Zealand 2026-05-20 20:56
1 2 3 4 5 279